Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2000
08/24/2000CA2371824A1 .beta.-alanine derivatives
08/24/2000CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000CA2363670A1 Chemical compounds
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362862A1 Bicyclic compounds and their use as integrin receptor ligands
08/24/2000CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists
08/24/2000CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000CA2362306A1 Chemical compounds
08/24/2000CA2362303A1 Growth hormone secretagogues
08/24/2000CA2362300A1 Human lipid-associated proteins
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000CA2362136A1 High molecular weight extracts of convolvulus arvensis (field bindweed)
08/24/2000CA2361273A1 Inhibitors for use in hemostasis and immune function
08/24/2000CA2329524A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines
08/24/2000CA2328877A1 Composition for treatment of external secretion disorders except hypolacrimation
08/23/2000EP1029547A1 Pharmaceutically active compounds and method for identifying same
08/23/2000EP1029541A1 Therapeutic or prophylactic agent for glomerulopathy
08/23/2000EP1029529A1 Composition for oxidative dyeing of keratinous fibres and dyeing process using same
08/23/2000EP1029043A1 Human receptor proteins; related reagents and methods
08/23/2000EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers
08/23/2000EP1028958A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d alpha antagonists
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028954A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028946A1 Indazole bioisostere replacement of catechol in therapeutically active compounds
08/23/2000EP1028748A1 Compositions providing for increased igf-i solubility
08/23/2000EP1028747A1 Novel igf-i composition and its use
08/23/2000EP1028746A1 Method for producing igf-i sustained-release formulations
08/23/2000EP1028744A2 Neuronal uses of bmp-11
08/23/2000EP1028738A1 Use of cytokines and mitogens to inhibit pathological immune responses
08/23/2000EP1028731A2 Stable antiandrogenic gel composition
08/23/2000EP1028729A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
08/23/2000EP1028720A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness
08/23/2000EP1028707A1 Sustained release ophthalmic compositions containing water soluble medicaments
08/23/2000EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
08/23/2000EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/23/2000EP0711289B1 Piperazine compounds used in therapy
08/23/2000EP0708772B1 IMIDAZO [4,5-c]PYRIDIN-4-AMINES
08/23/2000EP0666844B1 Inhibitors of farnesyl-protein transferase
08/23/2000EP0658159B1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/23/2000CN1264385A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
08/23/2000CN1264384A Fused 1,2,4-thiadiazine derivatives, their preparation method and use
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264379A Piperazine derivatives
08/23/2000CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/23/2000CN1264365A 3-benzoylindole derivatives and drugs containing the same
08/23/2000CN1264302A Treatment of diabetes with thiazolidinedione and sulphonylurea
08/23/2000CN1263774A Organic trace elements supplement
08/23/2000CN1263765A Compound oral liquid of cactus
08/23/2000CN1263763A Drug composition containing carboxyl oxime acide derivative
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055697C Phospholipi derivatives containing higher elements of the Vth main group
08/23/2000CN1055691C 3-alkylcarbonyl-thiadiazinenone
08/23/2000CN1055685C Heteroation-bearing ligands and metal complexes thereof
08/23/2000CN1055638C Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method
08/23/2000CN1055637C Medicine for treatment of mammary gland disease and method for producing thereof
08/23/2000CN1055635C Smoking stopping powder
08/23/2000CN1055624C Scorpion-and-ant oral liquid and its preparation method
08/22/2000USRE36832 N-heteroaryl-N'-phenylurea derivatives, their production and use
08/22/2000US6107482 Nitrogenous macrocyclic compounds
08/22/2000US6107345 Antidepressant; psychological disorders
08/22/2000US6107338 Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107328 Use of 5HT1B receptor antagonist for the treatment of vascular disease
08/22/2000US6107327 Therapeutic treatment for HIV infection
08/22/2000US6107324 5-HT2A receptor inverse agonists
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107315 Nervous system disorders
08/22/2000US6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/22/2000US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders
08/22/2000US6107307 Psychological disorders
08/22/2000US6107306 Heterocyclic compounds
08/22/2000US6107305 Antiproferative agent, antiinflammatory agents
08/22/2000US6107300 Arylamino fused pyrimidines
08/22/2000US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
08/22/2000US6107294 Nervous system and psychological disorders
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107288 Antiviral nucleoside combination
08/22/2000US6107284 Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments
08/22/2000US6107274 Enzyme inhibitors as hypoglycemic agents in treatment of type-ii diabetes
08/22/2000US6107094 In vitro modification of target rna by contacting solution of target and ribonuclease preferential for double-stranded rna with oligonucleotide complementary to target and including nucleotides modified to improve affinity/specificity
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics
08/22/2000US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2143246C Imidazodiazepines
08/22/2000CA2111002C Non-chlorofluorocarbon aerosol formulations
08/22/2000CA2085987C Piperidyl-substituted indoles
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047762A2 Enriched central nervous system cell populations
08/17/2000WO2000047752A2 Macular degeneration diagnostics and therapeutics
08/17/2000WO2000047729A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 1564